These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1302362)

  • 1. [Pulmonary cellular proliferation and its control during development of pulmonary hypertension].
    Cai YN
    Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):298-302. PubMed ID: 1302362
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
    Berg JT
    J Appl Physiol (1985); 2007 Oct; 103(4):1455. PubMed ID: 17916681
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from oncology to understand and treat pulmonary hypertension.
    Adnot S; Eddahibi S
    Int J Clin Pract Suppl; 2007 Dec; (158):19-25. PubMed ID: 18078390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension.
    Botney MD
    Am J Respir Crit Care Med; 1999 Feb; 159(2):361-4. PubMed ID: 9927344
    [No Abstract]   [Full Text] [Related]  

  • 5. Point:Counterpoint: Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
    Rabinovitch M; Chesler N; Molthen RC
    J Appl Physiol (1985); 2007 Oct; 103(4):1449-51. PubMed ID: 17363624
    [No Abstract]   [Full Text] [Related]  

  • 6. [Properties of potassium channels in pulmonary arterial smooth muscle cells in hypoxic pulmonary hypertension].
    Chen W
    Zhonghua Nei Ke Za Zhi; 1997; 36(1):5-6. PubMed ID: 9812551
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathology and pathobiology of pulmonary hypertension.
    Guignabert C; Dorfmuller P
    Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of structural remodeling in chronic pulmonary hypertension.
    Durmowicz AG; Stenmark KR
    Pediatr Rev; 1999 Nov; 20(11):e91-e102. PubMed ID: 10551895
    [No Abstract]   [Full Text] [Related]  

  • 9. Counterpoint: Chronic hypoxia-induced pulmonary hypertension does not lead to loss of pulmonary vasculature.
    McLoughlin P; McMurtry I
    J Appl Physiol (1985); 2007 Oct; 103(4):1451-3; discussion 1453-4. PubMed ID: 17916678
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary vascular remodelling. Considerations regarding the possible participation of growth peptides factors and related substances].
    Lopes AA; Aiello VD; Maeda NY; Ebaid M
    Arq Bras Cardiol; 1993 Feb; 60(2):107-14. PubMed ID: 8240046
    [No Abstract]   [Full Text] [Related]  

  • 11. Elastase and the pathobiology of unexplained pulmonary hypertension.
    Rabinovitch M
    Chest; 1998 Sep; 114(3 Suppl):213S-224S. PubMed ID: 9741572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art.
    Haworth SG
    Chest; 1988 Mar; 93(3 Suppl):133S-138S. PubMed ID: 3277815
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency.
    Thompson BT; Spence CR; Janssens SP; Joseph PM; Hales CA
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1512-7. PubMed ID: 8004307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effect of radix Astragali on hypoxia pulmonary hypertension in rats].
    Chen X; Ruan Y; Xi S; Si W; Zhang L
    Zhongguo Zhong Yao Za Zhi; 1997 Jul; 22(7):432-4, inside back cover. PubMed ID: 11038905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?
    Tuder RM; Zaiman AL
    Am J Respir Cell Mol Biol; 2002 Feb; 26(2):171-4. PubMed ID: 11804866
    [No Abstract]   [Full Text] [Related]  

  • 16. [Smooth muscle cells and atherogenesis].
    Larrue J; Desgranges C
    Arch Mal Coeur Vaiss; 1987 Sep; 80 Spec No():31-6. PubMed ID: 3118847
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypoxia and endothelial-smooth muscle cell interactions in the lung.
    Kourembanas S; Bernfield M
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):373-4. PubMed ID: 7917305
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension.
    Voelkel NF; Tuder RM
    Pulm Pharmacol Ther; 1997; 10(5-6):231-41. PubMed ID: 9778486
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary pulmonary hypertension.
    Hogg JC
    Chest; 1988 Mar; 93(3 Suppl):172S-175S. PubMed ID: 3277817
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathobiology of pulmonary hypertension. Extracellular matrix.
    Rabinovitch M
    Clin Chest Med; 2001 Sep; 22(3):433-49, viii. PubMed ID: 11590839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.